Avelumab Program Rollover Study
Sponsor: EMD Serono Research & Development Institute, Inc.
Sponsor score: 0
ClinicalTrials ID:NCT03815643
This study is focused on ensuring the continued safety and tolerability of the drug avelumab for patients with solid tumors who are already receiving this treatment as part of a previous study.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The purpose of this study is to keep monitoring the safety and how well patients tolerate avelumab, a medication used to treat solid tumors. This is for patients who are already part of a previous study involving avelumab and are continuing with the same treatment plan.
Eligibility Criteria
Inclusion Criteria
- Currently participating in an avelumab study sponsored by EMD Serono Research & Development Institute, Inc. / Merck KGaA, Darmstadt, Germany, or Merck Serono Co., Ltd (Japan).
- Currently receiving avelumab treatment or in long-term follow-up after treatment in a previous study.
- Agree to use highly effective birth control methods if there is a risk of pregnancy for both men and women on active treatment.
- Other specific criteria defined by the study may apply.
Exclusion Criteria
- Pregnant or breastfeeding individuals.
- Known allergy to any ingredients in the study treatment for those still on active treatment.
- Enrolled in the comparison group of the previous avelumab study.
- Withdrawn from the previous avelumab study for any reason.
- Any other reason determined by the study doctor that would prevent participation.
- Other specific criteria defined by the study may apply.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| HonorHealth Research Institute | 85258 | Scottsdale | Arizona |
| Highlands Oncology Group | 72703 | Fayetteville | Arkansas |
| University of California Davis Health System - Comprehensive Cancer Center | 95817 | Sacramento | California |
| Providence Medical Foundation | 95403 | Santa Rosa | California |
| St Joseph Heritage Healthcare | 95403 | Santa Rosa | California |
| Norwalk Hospital - The Whittingham Cancer Center | 06850 | Norwalk | Connecticut |
| Hematology - Oncology Associates of the Treasure Coast - Hematology-Oncology Associates of Treasure Coast | 34952 | Port Saint Lucie | Florida |
| Northwest Georgia Oncology Centers | 30060 | Marietta | Georgia |
| Maryland Oncology Hematology, P.A. | 20850 | Rockville | Maryland |
| Michigan State University | 48910 | Lansing | Michigan |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.